Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

CSE:BIOV - Post Discussion

BioVaxys Technology Corp. > 1.7 million shares traded 3 million in 3 days-consolidation
View:
Post by frankman on Nov 13, 2024 2:39pm

1.7 million shares traded 3 million in 3 days-consolidation

Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr
C ATS

50.1 0.065 · 0.07 63.0 0.07 +0.005 7.7 1,762.4 106 163
CSE - C 50.1 0.065 · 0.07 63.0 0.07 +0.005 7.7 885.0 53 72
NEO ATS - U   0.065     65.0 3 14
Omega - O   0.065     442.0 28 31
Chi-X - X   0.065     1.0   1
CX2 - H   0.065     316.1 19 29
CXD - D   0.0575 -0.0075 -11.5 5.9 0 7
TriAct - M   0.065     47.4 2 9
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities